(PDF) OA08 Efficacy and Safety of Sintilimab Combined With

OA08 Efficacy and Safety of Sintilimab Combined With 1st Line Chemotherapy in Advanced Squamous Cell Non-Small Cell Lung Cancer

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.10.018

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

December 1, 2018

Authors

Publisher

Elsevier BV

Related search

P027 Efficacy and Safety of Bevacizumab Combined With Chemotherapy for Second - Line and Above in Non - Squamous Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Efficacy and Safety of Icotinib as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy

English

Bevacizumab Combination Chemotherapy in Clinical Practice for Advanced Non-Squamous Non-Small Cell Lung Cancer

Japanese Journal of Lung Cancer

Respiratory Medicine

English

Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer

English

P025 Which Is the Optimal Immunotherapy for Advanced Non-Squamous Non-Small-Cell Lung Cancer in Combination With Chemotherapy?

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-94 Safety and Efficacy of First-Line Pemetrexed Versus Bevacizumab-Containing Regimens in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-70 Meta-Analysis of Metformin in Combination With Platinum Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.13-21 Clinical Efficacy and Safety of Apatinib Combined With EGFR - TKIs in Advanced Non-Small Cell Lung Cancer With EGFR - TKIs Resistance

Journal of Thoracic Oncology

Respiratory Medicine

English

Cost-Effectiveness of First-Line Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer Unsuitable for Chemotherapy

English